Study of BHV-1400 in IgA Nephropathy

Clinical trial NCT07054684 · RECRUITING

Trial details

NCT number: NCT07054684
Sponsor: Biohaven Therapeutics Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

IgA Nephropathy

Start date: 2025-07-30
Primary completion: 2027-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.